Esperion Therapeutics Has Raised (Dollar) 33 Million to Finance Clinical Trials

Medindia Health News Medindia largest health website in india. // via fulltextrssfeed.com

Esperion Therapeutics Has Raised (Dollar) 33 Million to Finance Clinical Trials Apr 26th 2013, 16:49 The Ann Arbor based company is currently in midst of the phase II trial of LDL-lowering pill, ETC-1002, which it says will be able to reduce levels of bad cholesterol by as much as 43 percent. The CEO of the company, Tim Mayleben said that the money generated will be used on the trials, adding that they expect to publish the results of the trial by June. Founded in 1998, Esperion was sold to Pfizer for $1.3 billion in 2004 before the company was relaunched in 2008 by Roger Newton, who led the development of Lipitor, which has so far generated $130 billion in sales. Source-Medindia

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions